Friday 28 February 2020

Boehringer Ingelheim appoints regional MD

DUBAI, January 8, 2020

Boehringer Ingelheim, a global pharmaceutical company, has appointed Mohammed Tawil as regional managing director for the Middle East, Turkey and Africa (META) region, in addition to his role as head of Human Pharmaceuticals.

Tawil will lead the company’s operations from its regional headquarters in Dubai, UAE.

Prior to joining META, Tawil was a regional business manager within the Emerging Markets region, based at the company’s headquarters in Germany. He was responsible for China, Mexico, Brazil and South America, where he successfully managed positive transformational changes across Boehringer Ingelheim’s Emerging Markets operations.

As regional managing director for Boehringer Ingelheim META, Tawil will focus on achieving growth and market leadership, while further developing innovative solutions that serve customers and patients across the Human Pharmaceuticals and Animal Health businesses.

Commenting on his new role, Tawil said: “I’m excited about taking on this role and look forward to contributing to the sustainable development of the business in the region. I see tremendous potential to bring more value to the communities that we operate in through two main factors.

“First, that the company has a strong focus on bringing innovative solutions to patients in an effort to better serve their needs. And secondly, our region is highly responsive and open to partnerships that would reshape the overall healthcare landscape.”

“Knowledge sharing and effective teamwork are among the main driving forces in Boehringer Ingelheim. The greatest successes I have witnessed in my international career were a direct result of the combined efforts of an exceptional diverse group of professionals. I am keen to ensure that we apply this approach not only to deliver results, but to make a difference for the generations to come,” Tawil added. – TradeArabia News Service


More Health & Environment Stories

calendarCalendar of Events